| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| Q0084 |
Chemotherapy administration by infusion technique only, per visit |
5,497 |
3,075 |
$392K |
| 99215 |
Prolong outpt/office vis |
8,633 |
6,224 |
$377K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,547 |
1,906 |
$209K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,949 |
3,206 |
$167K |
| 96415 |
|
2,082 |
1,103 |
$127K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,731 |
1,419 |
$111K |
| 99205 |
Prolong outpt/office vis |
641 |
606 |
$51K |
| 96367 |
|
1,624 |
953 |
$44K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,589 |
1,443 |
$36K |
| 96417 |
|
678 |
399 |
$23K |
| J1442 |
Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram |
120 |
25 |
$22K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
208 |
188 |
$14K |
| 99221 |
|
60 |
56 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
28 |
28 |
$3K |
| 96401 |
|
69 |
48 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
43 |
36 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,361 |
1,224 |
$1K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
36 |
24 |
$829.78 |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
399 |
206 |
$705.83 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,139 |
1,816 |
$449.59 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
38 |
14 |
$390.91 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,916 |
1,113 |
$250.41 |